Envoy Medical Inc. (COCH)
NASDAQ: COCH
· Real-Time Price · USD
0.91
-0.01 (-0.90%)
At close: Oct 15, 2025, 3:59 PM
0.91
0.53%
After-hours: Oct 15, 2025, 04:36 PM EDT
-0.90% (1D)
| Bid | 0.89 |
| Market Cap | 19.56M |
| Revenue (ttm) | 222K |
| Net Income (ttm) | -21.27M |
| EPS (ttm) | -1.41 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | -0.67 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 0.91 |
| Volume | 730,528 |
| Avg. Volume (20D) | 2,918,265 |
| Open | 0.95 |
| Previous Close | 0.92 |
| Day's Range | 0.89 - 0.95 |
| 52-Week Range | 0.74 - 3.09 |
| Beta | 2.07 |
| Ex-Dividend Date | n/a |
About COCH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEnvoy Medical Inc. is scheduled to release its earnings on
Nov 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-41.5%
Envoy Medical shares are trading lower after the c...
Unlock content with
Pro Subscription
1 week ago
+97.07%
Envoy Medical shares are trading higher after the company announced it received FDA approval to expand its clinical trial for the fully implanted Acclaim cochlear implant to the final stage based on 3-month data from the first 10 patients
